A team of researchers led by ETH Professor Martin Fussenegger from the Department of Biosystems Science and Engineering (D-BSSE) in Basel has come up with an innovative and simplified approach for producing therapeutically effective synthetic designer...
Original Article: Engineering non-immune cells to kill cancer cells
NEXT ARTICLE